None listed
Conditions
Interventions
Medical Device : In patients who implantaed Intica 7 VR-T DX(Biotronik, Germany) ICD are randomly assgned three months after implantation. Patients with atrial sensing on can detect atrial fibrillatio
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Eligible patients for the present study are those who will undergo or have undergone implantation of Intrica 7 VR-T DX ICD with atrial sensing function(Biotronik, Germany) within previous 90 days before enrollment. Inclusion criteria are as follows: 1) age = 19 years, 2) indication for ICDimplantationaccording to guidelines 3) atrial fibrillation didn't detect by ECG or holter test within the past 1 year from the ICD implantation, and 4) CHA2DS2VASc score =1 point in male or = 2 in female
Exclusion criteria
Exclusion criteria: Patients who met any of the following criteria are excluded: 1) persistent or permanent atrial fibrillation (AF) 2) atrial fibrillation detected by electrocardiogram or holter test within the past 1 year from the ICD implantation 3)history of catheter or surgical ablation of AF or taking anti arrhythmic drug, 4) scheduled to undergo heart transplant within 1 year, 5)life expectancy < 1 year, or 6) requiring atrial pacing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac implantable electronic device-detected or clinical atrial fibrillation | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications associated with atrial fibrillation;ventricular arrhythmia;major adverse composie events;atrial lead sensing stability | — |
Countries
Korea, Republic of
Contacts
Public ContactSeung-Jung Park
Samsung Medical Center
Outcome results
None listed